News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Critics say stem cell panel skirting the law; Board didn't give proper notice of meeting, they say

By San Francisco Chronicle, San Francisco Chronicle | 12.16.2004

Even before its first meeting, the board being created to direct California's $3 billion stem cell program is stirring up...

Technologies

Editorial: Stem cell czar?

By admin Sacramento Bee | 12.16.2004
It's not very surprising that Gov. Arnold Schwarzenegger and other state leaders have anointed Robert Klein II, a Bay Area...
Biotech & Pharma

'Coronation' of committee head on stem cell funds disturbs some

By Terri Somers, San Diego Union-Tribune | 12.15.2004
Robert Klein was chairman of the campaign for Proposition 71, the stem cell ballot measure approved by voters last month...
Biotech & Pharma

Implementation of Proposition 71 [RealAudio]

By Spencer Michels, Marcy Darnovsky, Deborah Ortiz, David Magnus, Keith Yamamoto, Robert Birgeneau, and Ted Love, KQED Forum | 12.15.2004
Media Coverage

Technology Allows Choice Embryo Screening Stirs Ethics Debate

By Rob Stein, Washington Post | 12.14.2004
Kristen and John Magill adore all three of their daughters -- 11-year-old twins and a 5-year-old baby sister. But when...
Human Genetic Modification

Stem Cell Post Likely to Go to Klein

By Megan Garvey, Los Angeles Times | 12.14.2004
The man who led the Prop. 71 campaign receives three of the four nominations to be chairman of the state's...
Biotech & Pharma

Charles Halpern Letter to the Attorney General

By Charles Halpern | 12.14.2004

Dear Mr. Attorney General:

I am writing to request you to take action pursuant to your duties under the Bagley-Keene...

U.S. States

Nominee pool grows for stem-cell czar

By San Francisco Chronicle, San Francisco Chronicle | 12.12.2004

Some of the architects assembling California's $3 billion stem cell project are pushing for a competitive process to select a...

Biotech & Pharma